Skip to main content
Pharmaceutical product and formulation background
Pharmaceutical Division

Eltrombopag Olamine

Eltrombopag Olamine is used to treat thrombocytopenia in patients with chronic immune thrombocytopenia.

Under developmentThrombocytopeniaCAS 496775-62-3
✓Quality Assured
✓Thrombopoietin receptor agonist
✓Under development

Detailed technical, regulatory, and supply information is available for commercial evaluation.

Technical Overview

Eltrombopag Olamine – CAS 496775-62-3

Under development

CAS Number

496775-62-3

Category

Thrombocytopenia

Therapeutic Class

Thrombopoietin receptor agonist

Description

Eltrombopag Olamine is used to treat thrombocytopenia in patients with chronic immune thrombocytopenia.

Applications

  • Chronic immune thrombocytopenia
  • Aplastic anemia

Handling & Supply Details

Packaging

Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.

Product Inquiry

Disclaimer

Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.